Retatrutide

Retatrutide: First-in-Class Triple Hormone Receptor Agonist for Advanced Research

Retatrutide represents a groundbreaking advancement in peptide science. As a first-in-class triple agonist targeting the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, it offers a unique multimodal approach for metabolic research unlike any single- or dual-agonist peptide.

This innovative peptide is designed to simultaneously engage three distinct metabolic pathways, making it a highly valuable tool for studying energy expenditure, appetite regulation, lipid metabolism, and glycemic control in preclinical models.

Our Retatrutide is synthesized under stringent quality controls, delivering ≥99% purity verified by HPLC-MS. Each order contains 10 lyophilized vials in your chosen strength.

Available Strengths & SKUs:

• 5mg (RT5) – $70.25

• 10mg (RT10) – $95.60

• 15mg (RT15) – $128.65

• 20mg (RT20) – $159.75

• 30mg (RT30) – $227.75

• 40mg (RT40) – $270.25

• 50mg (RT50) – $324.25

• 60mg (RT60) – $352.75

Key Research Applications:

• Triple hormone receptor co-activation studies (GLP-1/GIP/glucagon)

• Energy expenditure and thermogenesis research

• Appetite suppression and satiety pathway analysis

• Lipid and glucose metabolism investigations

• Comparative efficacy studies against dual and single agonists

• Metabolic rate modulation research

Product Specifications:

• Format: Lyophilized powder

• Quantity: 10 vials per pack

• Purity: ≥99% (HPLC-MS certified)

• Storage: Refrigerated (2-8°C), desiccated, protect from light

• For laboratory research use only. Not for human consumption.

Why Choose ChemNexis Pharma Retatrutide?

• Triple agonist mechanism – unique research potential

• Third-party purity verification

• Wide strength range for dose-response studies

• Secure, discreet global shipping

• Expert research support

SEO Title

Retatrutide 5mg to 60mg – Triple GLP-1/GIP/Glucagon Agonist | ChemNexis Pharma

SEO Meta Description

Shop Retatrutide peptide – first-in-class triple agonist (GLP-1, GIP & glucagon). 5mg to 60mg strengths, ≥99% purity, 10 vials per pack. For advanced metabolic research.